305 related articles for article (PubMed ID: 36234758)
1. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of
Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758
[TBL] [Abstract][Full Text] [Related]
2. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology.
Tu H; Feng Y; Wang W; Zhou H; Cai Q; Feng Y
Chem Biol Drug Des; 2024 Jan; 103(1):e14413. PubMed ID: 38040415
[TBL] [Abstract][Full Text] [Related]
3. [Study on molecular mechanism of Solanum nigrum in treatment of hepatocarcinoma based on network pharmacology and molecular docking].
Liu JH; Lyu DY; Zhou HM; Kuang WH; Chen ZX; Zhang SJ
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):163-168. PubMed ID: 32237426
[TBL] [Abstract][Full Text] [Related]
4. Identification of peanut skin components for treating hepatocellular carcinoma via network pharmacology and in vitro experiments.
Li S; Liu W; Wang TT; Chen TQ; Guo JC
Chem Biol Drug Des; 2024 Jan; 103(1):e14428. PubMed ID: 38230768
[TBL] [Abstract][Full Text] [Related]
5. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
[TBL] [Abstract][Full Text] [Related]
6. Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology.
Yu Q; Chen Z; Liu M; Meng Y; Li X; Li B; Du J
J Ethnopharmacol; 2022 Oct; 297():115531. PubMed ID: 35840058
[TBL] [Abstract][Full Text] [Related]
7. Lobelia chinensis Lour inhibits the progression of hepatocellular carcinoma via the regulation of the PTEN/AKT signaling pathway in vivo and in vitro.
Luo J; Chen QX; Li P; Yu H; Yu L; Lu JL; Yin HZ; Huang BJ; Zhang SJ
J Ethnopharmacol; 2024 Jan; 318(Pt A):116886. PubMed ID: 37429502
[TBL] [Abstract][Full Text] [Related]
8. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma.
Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
[TBL] [Abstract][Full Text] [Related]
9. Advanced network pharmacology study reveals multi-pathway and multi-gene regulatory molecular mechanism of Bacopa monnieri in liver cancer based on data mining, molecular modeling, and microarray data analysis.
Sadaqat M; Qasim M; Tahir Ul Qamar M; Masoud MS; Ashfaq UA; Noor F; Fatima K; Allemailem KS; Alrumaihi F; Almatroudi A
Comput Biol Med; 2023 Jul; 161():107059. PubMed ID: 37244150
[TBL] [Abstract][Full Text] [Related]
10. Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of
Khan SA; Lee TKW
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628212
[TBL] [Abstract][Full Text] [Related]
11. Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis.
Wei J; Ma L; Liu W; Wang Y; Shen C; Zhao X; Zhao C
J Ethnopharmacol; 2021 Aug; 276():114174. PubMed ID: 33932512
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
13. Integrated strategy of network pharmacology, molecular docking, HPLC-DAD and mice model for exploring active ingredients and pharmacological mechanisms of Penthorum chinense Pursh against alcoholic liver injury.
Jiang Y; Zhong M; Zhan H; Tao X; Zhang Y; Mao J; Geng Z; Gao B
J Ethnopharmacol; 2022 Nov; 298():115589. PubMed ID: 35926779
[TBL] [Abstract][Full Text] [Related]
14. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
[TBL] [Abstract][Full Text] [Related]
15. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.
Wang LL; Liao C; Li XQ; Dai R; Ren QW; Shi HL; Wang XP; Feng XS; Chao X
Med Sci Monit; 2021 Jan; 27():e927624. PubMed ID: 33436534
[TBL] [Abstract][Full Text] [Related]
16. Active ingredients and molecular targets of
Zheng Y; Ji S; Li X; Feng Q
PeerJ; 2022; 10():e13737. PubMed ID: 35873910
[TBL] [Abstract][Full Text] [Related]
17. Network Pharmacology-Based Approach Combined with Bioinformatic Analytics to Elucidate the Potential of Curcumol against Hepatocellular Carcinoma.
Huang X; Rehman HM; Szöllősi AG; Zhou S
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456457
[TBL] [Abstract][Full Text] [Related]
18. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
19. Exploring the mechanisms underlying the therapeutic effect of the
Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]